GLP-1RAs Linked to Lower Heart Failure Risk in Obstructive Sleep Apnea
TL;DR: A 2026 real-world study in Journal of Clinical Sleep Medicine found that glucagon-like peptide-1 receptor agonist use was associated with lower 3-year cardiovascular-event risk in adults with obesity and obstructive sleep apnea. Key Findings 18,523 matched pairs: Propensity matching compared GLP-1 receptor agonist users with similar non-users who had obesity and obstructive sleep apnea. …
